Argenx SE
ARGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001697862
No open-market purchases or sales by Argenx SE insiders were filed in the last 90 days; 510 institutions reported holding it in 13F filings for Q2 2026, worth $26.1B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Argenx SE as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 208
- +29 vs. Q3 2021
- Shares held
- 28.9M
- +551.4K (+1.9%) vs. Q3 2021
- Total value
- $10.1B
- +$1.56B (+18.2%) vs. Q3 2021
- New holders
- 51
- 71 more added
- Sold out
- 22
- 61 more reduced
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 510 | $26.1B |
| Q1 2026 | 478 | $21.1B |
| Q4 2025 | 510 | $25.0B |
| Q3 2025 | 470 | $22.5B |
| Q2 2025 | 439 | $17.7B |
| Q1 2025 | 448 | $19.7B |
| Q4 2024 | 397 | $21.0B |
| Q3 2024 | 358 | $19.0B |
| Q2 2024 | 336 | $14.7B |
| Q1 2024 | 328 | $13.4B |
| Q4 2023 | 346 | $12.5B |
| Q3 2023 | 341 | $15.9B |
| Q2 2023 | 290 | $12.0B |
| Q1 2023 | 272 | $11.6B |
| Q4 2022 | 271 | $11.6B |
| Q3 2022 | 255 | $11.2B |
| Q2 2022 | 232 | $12.4B |
| Q1 2022 | 199 | $10.2B |
| Q4 2021 | 208 | $10.1B |
| Q3 2021 | 182 | $8.57B |
| Q2 2021 | 177 | $8.57B |
| Q1 2021 | 191 | $7.84B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Argenx SE; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 729,810 | $255.6M | 0.01% | −32,173−4.2% | Reduced |
| Jennison Associates LLC | 824,571 | $288.8M | 0.18% | −7,574−0.9% | Reduced |
| Avoro Capital Advisors LLC | 965,000 | $337.9M | 5.75% | +18,500+2.0% | Added |
| Bellevue Group AG | 997,038 | $349.2M | 3.60% | +13,100+1.3% | Added |
| Baker Bros. Advisors LP | 1,119,557 | $392.1M | 1.91% | 00.0% | Unchanged |
| Artisan Partners Limited Partnership | 3,180,665 | $1.11B | 1.33% | +310,573+10.8% | Added |
| FMR LLC | 4,586,399 | $1.61B | 0.12% | +125,986+2.8% | Added |
| Price T Rowe Associates Inc | 5,603,556 | $1.96B | 0.18% | +36,318+0.7% | Added |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −170,926−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −57,886−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −49,526−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −35,874−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −16,902−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −12,854−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,657−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −2,145−100.0% | Sold out |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −1,939−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −1,570−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −1,050−100.0% | Sold out |
| Sumitomo Mitsui Trust Holdings, Inc. | 0 | $0 | 0.00% | −1,038−100.0% | Sold out |
| Greenleaf Trust | 0 | $0 | 0.00% | −870−100.0% | Sold out |
| Veriti Management LLC | 0 | $0 | 0.00% | −664−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −367−100.0% | Sold out |
| Evolution Wealth Advisors, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Column Capital Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| Towarzystwo Funduszy Inwestycyjnych Pzu SA | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |